Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]
Constellation Brands Inc. (NYSE: STZ) CEO Robert Sands, discusses continued market penetration of the company’s Mexican beer brands, Pacifico, Victoria in US, and global cannabis strategy, including potential of CBD beverages, and Canopy Growth (NYSE: […]
Canaccord Genuity 2nd Annual U.S. Cannabis Symposium Conference on October 3, 2019 in Toronto, Canada- Alliance Global Partners Consumer Cannabis Conference on October 3, 2019 in New York City- Company to share its growth strategy […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
